Considerations for cancer immunotherapy during the COVID-19 pandemic

Simple item page
dc.contributor.authorKanjanapan, Yada
dc.contributor.authorYip, Desmond
dc.date.accessioned2023-02-02T23:04:58Z
dc.date.issued2020
dc.date.updated2023-10-22T07:16:11Z
dc.description.abstractCancer immunotherapy during the COVID-19 pandemic presents management challenges related to immune-related toxicities, requiring careful patient selection.
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0025-729Xen_AU
dc.identifier.urihttp://hdl.handle.net/1885/284597
dc.language.isoen_AUen_AU
dc.publisherAustralasian Medical Association
dc.rights© 2020 AMPCo Pty Ltd
dc.sourceMedical Journal of Australia
dc.titleConsiderations for cancer immunotherapy during the COVID-19 pandemic
dc.typeJournal article
local.bibliographicCitation.issue9en_AU
local.bibliographicCitation.lastpage392.e1en_AU
local.bibliographicCitation.startpage390en_AU
local.contributor.affiliationKanjanapan, Yada, College of Health and Medicine, ANUen_AU
local.contributor.affiliationYip, Desmond, College of Health and Medicine, ANUen_AU
local.contributor.authoruidKanjanapan, Yada, t945en_AU
local.contributor.authoruidYip, Desmond, u5086006en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor321104 - Cancer therapy (excl. chemotherapy and radiation therapy)en_AU
local.identifier.absfor320700 - Medical microbiologyen_AU
local.identifier.ariespublicationa383154xPUB15351en_AU
local.identifier.citationvolume213en_AU
local.identifier.doi10.5694/mja2.50805en_AU
local.identifier.thomsonIDWOS:000577023400001
local.publisher.urlhttps://www.wiley.com/en-gben_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Medical Journal of Australia - 2020 - Kanjanapan - Considerations for cancer immunotherapy during the COVID‐19 pandemic.pdf
Size:
243.51 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS